News and Document archive source
copyrighted material disclaimer at bottom of page

NewsMinecabal-elitecorporatepharmaceutical — Viewing Item


Cholesterol drug causes kidney damage contradicting fda { May 24 2005 }

Original Source Link: (May no longer be active)
   http://www.washingtonpost.com/wp-dyn/content/article/2005/05/24/AR2005052400100.html

http://www.washingtonpost.com/wp-dyn/content/article/2005/05/24/AR2005052400100.html

Study Contradicts FDA on Crestor Risks

By JAMIE STENGLE
The Associated Press
Tuesday, May 24, 2005; 9:52 AM



DALLAS -- New research seems to challenge a Food and Drug Administration decision not to pull the cholesterol-lowering drug Crestor off the market, with data showing it causes more kidney and muscle problems than rival medications.

The FDA in March contended Crestor's risks were no greater than its competitors, and it rejected consumer efforts to remove the drug, made by AstraZeneca PLC, from store shelves. Instead, the FDA ordered a warning on the label, saying Crestor could cause serious muscle problems and kidney damage, especially among Asians.

The new study, based on side effects reported to the FDA, said kidney problems and muscle weakness were two to eight times more frequent among Crestor users than those taking other cholesterol-lowering medications like Lipitor, Zocor and Pravachol.

Even so, results from the study published online Monday by the American Heart Association's journal Circulation said the cholesterol drugs _ called statins and taken by millions of Americans _ showed that most are very safe and that the risk of serious problems, even with Crestor, are very low.

FDA spokeswoman Laura Alvey said that the new analysis yielded no new information. "We haven't found any convincing evidence that Crestor poses any more of a risk than the other statins," she said.

AstraZeneca said the higher reports of side effects may have been the result of heightened awareness of the problems with another cholesterol drug, Baycol, which was pulled from the market in 2001. Crestor went on the market two years later.

"We strongly disagree with the conclusions of this study," the company said in a statement.

An estimated 20 million Americans are believed to be taking statins, which researchers say are still the best drugs for lowering high cholesterol and reducing the risk of heart disease and stroke.

Many of the drugs cause muscle problems among some people, but experts advise patients to talk to their doctors about lowering their dosage, which can solve the problem. Doctors said patients should not stop taking statins but should discuss any problems with their doctors.

In a teleconference, doctors reiterated that the drugs are safe overall.

"Statins in general are very safe drugs and they can be life-saving to high-risk patients," said Dr. Scott Grundy, of the University of Texas Southwestern Medical Center in Dallas.

For the new study, researchers analyzed reports of side effects sent to the FDA for Crestor and compared them to the rates during the same time period for three other statins: Lipitor, Zocor and Pravachol.

"What we've shown is that amongst this family of drugs, Crestor has a poorer safety profile, but that the overall rate of adverse effects is still quite low," said study leader Dr. Richard Karas, director of the preventive cardiology at Tufts-New England Medical Center in Boston.

Karas, who has received research grants and speaker fees from several drug companies _ including the maker of Crestor _ said that, generally, the people who should consider taking Crestor are those who are unable to lower their cholesterol enough with other drugs or those who may be allergic to other drugs.

The year after Crestor came on the market in October 2003, more than 5 million prescriptions were filled for the drug.

The researchers also compared the rate of adverse event reports during the first year of marketing for the current statins and the earlier withdrawn drug, Baycol.

Complications were more common with Crestor than the other three statins available, but less than half the rate of those reported during the first year of Baycol's use. But even for Crestor, the absolute risk of a serious problem was very low _ 1 in 35,862.

An expert and the study's authors agree that there were limitations to the study, including the possible underreporting of side effects. Also the removal of Baycol from the market likely heightened public awareness of drug safety concerns.

Dr. Benjamin Ansell, co-director of the cholesterol treatment program at UCLA medical center in Los Angeles, suggested there also is a tendency to overreport side effects, especially when a drug, like Crestor, has gotten a lot of media attention.

"I would say the study has to be interpreted with skepticism and recognizing its imitations," Ansell said.

But one consumer advocate said the warning should be heeded.

"This will be further reason to take the drug off the market," said Dr. Sidney Wolfe of the group Public Citizen. He said his group would try again to get the drug off the market.

___

On the Net:

American Heart Association: http://www.americanheart.org

2005 The Associated Press



40 percent of americans take prescription drugs
ADD drugs give hallucinations of bugs and snakes { March 22 2006 }
American painkiller use skyrocketing
Anti depresents linked to suicide
Antibiotic causes liver damage
Antidepressant use by adults surges { December 3 2004 }
Antidepressants addictive to some people { August 6 2006 }
Antidepressants remove obsessive focus of love
Antidepressiants increases chance of suicide { December 13 2006 }
Arthritis drugs causing cancer in childen { April 29 2008 }
Bayer sent riskier drug asia latinamerica { May 22 2003 }
Birth defects from paxil in pregnant women { December 8 2005 }
Canada makes drug deals with 2 states against fda wishes { October 5 2004 }
Cholesterol drug causes kidney damage contradicting fda { May 24 2005 }
Cholesterol meds lower test results not improving health { January 15 2008 }
Clinical trials biased by profit funding
Company hid heartattack data for painkiller { December 8 2005 }
Congressman moves retired to drug lobby
Dc council legislation blocks pharmaceutical price gounging { September 21 2005 }
Doctor gives anti depressants to 4 yr old girl
Doctors get kickbacks to promote drugs
Doctors prescribe paxil whenever asked { April 27 2005 }
Drug aleve increases stroke heart attack risk { December 21 2004 }
Drug bill well financed victory
Drug company criminal charges { May 31 2003 }
Drug firms hide studies showing suicidal behavior { September 10 2004 }
Drug firms hype up diseases to boost sales
Drug leader at NIH takes pharmaceutical money { December 22 2004 }
Fda accused too cozy with pharmaceuticals { November 18 2004 }
Fda approval surprises many doctors
Fda prevented drug expert from speaking on anti depressants { April 16 2004 }
Fda wants suicide warning on anti depressants { March 23 2004 }
Fda whistle blower seeks legal help { November 24 2004 }
Fraud studies made by drug company { March 2008 }
Man arrested if not medicating child with drugs { June 7 2004 }
Mccain knocks steroids baseball
Minnesota school shooter using prozac and others { March 26 2005 }
More anti depressant drug warnings by fda
New diabetes pill poses deadly risk
New york state sues paxil company over coverup { June 3 2004 }
Newer antipsychotic drugs more costly less effective { September 20 2005 }
Parents reverse child hyper activity without drugs { December 22 2006 }
Paxil link found with birth defects
Pharmaceutical cholesterol drugs not lowering risk
Pharmaceutical companies court doctors for sells { April 11 2008 }
Pharmaceutical companies using tax exempt charities { June 28 2006 }
Pharmaceutical secrecy on antidepressant data { January 29 2004 }
Pharmaceuticals in tap water through sewage { March 10 2008 }
Pharmaceuticals pay fda more for speedy approvals { November 22 2006 }
Return of vioxx unusual not unprecendented
Rise of european behavior controlling drug
Ritalin could be dangerous to heart { February 10 2006 }
Senators told fda too cozy with drug industry { November 18 2004 }
Sharp rise in ritalin { July 19 2003 }
Sleeping pill causes sleep driving { March 15 2007 }
Sleeping pills once a day increase death rate { March 23 2006 }
Statin drug takers suffer heart attacks anyway
Study criticizes painkiller marketing { January 25 2005 }
Study drugs for students growing { June 11 2006 }
Study shows no good effect from anti depressants { February 25 2008 }
Suicide risk increase with antidepressants { February 18 2005 }
Supreme court allows pharmaceutical to bulldoze homes { June 23 2005 }
Teens increasing pharmaceutical drug abuse { April 21 2005 }
Teens use pharmaceutical drugs to get high { December 21 2006 }
Unapproved drug tested on children in nigeria { May 7 2006 }
Unfavorable drug studies never reported
Viox risk seen with short term use { May 17 2006 }
Women participating in lilly drug trial hangs self { February 9 2004 }

Files Listed: 68



Correction/submissions

CIA FOIA Archive

National Security
Archives
Support one-state solution for Israel and Palestine Tea Party bumper stickers JFK for Dummies, The Assassination made simple